Robert W. Baird initiated coverage on shares of Astrana Health (NASDAQ:ASTH – Get Free Report) in a research note issued on Thursday, Marketbeat reports. The brokerage set an “outperform” rating and a $54.00 price target on the stock. Robert W. Baird’s target price points to a potential upside of 30.34% from the company’s previous close. […]